Article
Omeprazole treatment: genotoxicity biomarkers, and potential to induce CYP1A2 activity in humans.
Human & experimental toxicology - 1 Mar 2004
Sinués Blanca, Fanlo Ana, Bernal Maria Luisa, Val Marta, Mayayo Esteban
Abstract excerpt
Omeprazole is one of the most used acid-suppressing medications. This fact emphasizes the questions concerning the safety of this compound. Healthy volunteers (n=33) were included in this prospective study. All study subjects were analysed for their CYP2C19 genotype. Of the 33 individuals, 24 were homozygous for the wild type CYP2C19*1 allele, 7 were heterozygous for the CYP2C19*2 variant allele, and 2 were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
